CaseyD.Stefanski et al. showed that adriamycin resistance in breast cancer cells results from the loss of APC through a diminished response to DNA damage, while the inhibitory effect of DNA damage can be blunted by the inhibitory effect of DNA repair (Stefanski et al., 2019). Here, APC is linked to breast cancer.